Dätwyler Holding Inc.
Gotthardstrasse 31, 6460 Altdorf, Switzerland
General inquiries, media & investor relations: info@datwyler.com
Healthcare solutions: healthcare@datwyler.com
Connect with us on socials – LinkedIn

You didn’t get into biotech to become a packaging expert. We did. 

Datwyler is a leading provider of high-quality, system-critical elastomer components. We materialize ideas for a safer, smarter and more sustainable world.

Leading Market Positions

As a high-tech company, we focus on pharmaceutical packaging and hold leading positions in attractive global markets such as Healthcare, Mobility, Connectivity, General Industry and Food & Beverage.

Experience & Expertise

Our elastomer components make a significant contribution to the functionality and quality of customer systems, while at the same time contributing very little to the total cost of these systems. The pharmaceutical and biotech markets require high-end quality without compromise. As a Swiss-based, leading supplier and key player in the global healthcare industry, Datwyler is a global thought leader with more than 100 years of experience and a good intuition for future trends.

Global Production Footprint

With 27 plants on four continents, Datwyler has a global production footprint with its own elastomer mixing plants and mould shops. For us, a global strategic approach with a local/regional presence is a key success factor. Our manufacturing set-up guarantees identical quality standards on a global level while providing local-for-local manufacturing capacities and technical support. This enables us to meet our customers’ needs for flexible and reliable supply chains in order to ensure business continuity.

Datwyler’s Components Make the Difference

Improving the lives of patients – every day with every product. We share this aspiration with our Healthcare customers. We, as an industrial supplier, provide our customers with the necessary applications that not only complete their products, but also make them reliable. By meeting the high expectations of the Healthcare market, we make the future possible.

Many years of expertise combined with our spirit of innovation make us a global pioneer in the Healthcare industry. Setting new industry standards is one of our strengths. Together with our customers, we develop precisely tailored components for a wide range of products – from the initial idea to the final delivery. Our diversified pharmaceutical packaging portfolio, includes components for:

Datwyler - Pen injector on armDatwyler Launches Industry’s First 20mL Universal Plunger for Large-Volume On-Body Delivery

Datwyler expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL. The launch responds to rising demand for on-body devices for subcutaneous (SC) delivery of biotherapeutics to patients seeking convenient at-home care.

  • Datwyler’s NeoFlex™ plunger for 20mL cartridges helps the industry meet rising demand for on-body delivery of higher dose therapies.
  • The pre-verified solution helps pharmaceutical and medical device manufactures speed time to market.
  • Compatible with all applicable cartridges on the market, Datwyler’s new plunger supports industry collaboration to advance at-home patient care.

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group. The collaboration enables convenient on-body delivery of higher dose therapies like anti-cancer treatments and monoclonal antibodies. It utilizes a pre-verified large-volume platform solution to speed time to market and meets evolving industry needs amid shift from hospital to home administration.

Assurance in GLP-1 Drug Delivery: A Checklist to Achieve Compatibility, Compliance, and Confidence

This checklist outlines six critical considerations for selecting primary packaging components for GLP-1 therapies, including formulation compatibility, functional performance, device integration, regulatory compliance, supply chain resilience, and lifecycle management. It provides practical criteria for reducing risk, protecting drug stability, and supporting reliable self-administration.

 

Find more information and details on our website – https://healthcare.datwyler.com/